|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||1.8190 - 2.0050|
|52 Week Range||1.6070 - 6.8800|
|Beta (3Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
TORONTO, Sept. 19, 2019 /PRNewswire/ - The Green Organic Dutchman Holdings Ltd. (the "Company" or "TGOD") (TGOD.TO) (TGODF), a leading producer of premium certified organic cannabis, is pleased to announce that it is hosting site visits for analysts at its Hamilton and Valleyfield facilities on September 19-20. Beyond construction timelines, for the first time the Company is sharing Canadian production ramp-up and other updates which are available on TGOD's website at www.tgod.ca.
Toronto, Ontario--(Newsfile Corp. - September 16, 2019) - Capital 10X announces the release of an Initiation Report on the Organic Cannabis Market that features The Green Organic Dutchman among other organic cannabis producers. Cannot view this video? Visit:https://capital10x.com/initiation-organic-cannabis-market/Executive SummaryThe global market for organic products is currently worth $160 billion and is forecast to grow to $323 billion by 2024, a 15% annual growth rate. Organic sales have been strong for decades growing at ...
TORONTO , Sept. 12, 2019 /CNW/ - The Green Organic Dutchman Holdings Ltd. (the "Company" or "TGOD") (TGOD.TO) (TGODF), a leading producer of premium certified organic cannabis, is pleased to announce that following its launch in Ontario at the end of August, which marked the Company's entrance into Canada's recreational market, initial demand has exceeded expectations. TGOD's high-THC signature strain, Unite Organic, is performing well online and at dispensaries, triggering a second order from the OCS earlier than initially anticipated.
After a weak couple of months, cannabis stocks rallied in the first week of September . That rally seems to have stalled so far in the second week of the month. S3 Partners analyst Ihor Dusaniwsy said ...
Green Organic Dutchman Holdings (TGODF) would seem to be a cannabis company many in the market would be supporting and rooting for, primarily because of its focus on organic cannabis and the accompanying premium price and wide margins that come with it.Yet, the market hasn't been especially kind to Green Organic, as it continues to experience downward pressure on its share price, and that's likely to continue for awhile because of the recent announcement by Aurora Cannabis (ACB) that it had sold off its position in the company, although it retains $22.3 million in TGODF warrants.There are a number of pros and cons with TGODF, including little in the way of revenue, upcoming increase in production capacity, uncertainty about level of demand for organic cannabis products, its positive results in regard to organic cannabinoid dissolvables, and the aforementioned loss of Aurora Cannabis as a distribution source.Because of the unknown negative catalysts listed above, TGODF is a risky stock because it may not be able to offset those catalysts with its positive catalysts.What's interesting is if it is able to prove it can overcome those possible obstacles, it could surprise a lot of investors to the upside. For that reason, it does have a high reward in relationship to risk, but it's something many investors may want to wait on, especially in relationship to how much the demand for organic cannabis actually is.Production capacityAlthough there have been some delays in development of its two major facilities, the company is coming close to completing them, which will bring annual production capacity to a little above 200,000 kilograms, making it the largest organic cannabis producer in the world.Its 166,000-square-foot Hamilton, Ontario facility will have the capacity to produce approximately 17,500 kilograms a year of certified-organic cannabis, while its 1.3-million-square-foot greenhouse facility in Valleyfield, Quebec will pruduce up to 185,000 kilograms a year at full capacity.This is by far the most important development for the company at this stage of its growth.A huge benefit Green Organic has gotten from the investment from Aurora Cannabis is Aurora, via Aurora Larssen Projects, which was behind the building of the cannabis facilities, with the goal of meeting the standards of Sky Class. It also had help from Aurora Larssen Projects on its smaller facility.In the current quarter Hamilton is expected to reach full production capacity, and its Valleyfield facility will reach a capacity of 65,000 kilograms annually by the end of 2019, while reaching its full 185,000 kilograms in annual capacity in 2021.One of the reasons for the market not bidding it up has been the fact the facilities had originally been slated for completion in the fourth quarter of 2018. That's the key reason why its revenue results have been so dismal. That will probably change.Finally, if the company is able to boost revenue, its margins should be somewhat close to what Aurora generates, and that means the potential to move toward profitability within a couple of years.Issue of demandA major concern for TGODF is whether or not demand for organic cannabis will align with the robust supply coming down its pipeline. It's one thing to produce a lot of cannabis, it's another thing to have an available market to consume it.On the surface it seems a no-brainer that organic cannabis will be very popular, but when the choice comes down to costs, a lot of consumers, even though they give lip service to preferring organic cannabis, could in reality go with less expensive options.There is also the issue of how much medical insurance will cover if costs become an issue from that point of view.Another huge factor in Canada is TGODF has only three supply deals in place with Canadian provinces. Until it is able to land more deals, it's going to be limited on the demand side; that will take time, even as its production capacity ramps up.Part of the reason for that was TGODF was late to the game, so is playing catch-up with its competitors. The company also will struggle to brand its products because of the brands that have already been gaining share over the last year.One positive there is the slow pace of Health Canada in licensing dispensaries and retail outlets may allow TGODF to compete on a more level playing field in some markets.This is why the loss of Aurora Cannabis as a wholesale buyer hurts the company so much. It may have had lower margins, but it would have been a key generator of revenue as the company completed its facilities. More than likely TGODF increase its marketing budget in order to make up for that huge loss in revenue.When considering it has over 202,000 kilograms a year coming on-line in 2021, and it only competes in three Canadian provinces at this time (it has some overseas markets it compete in), TGODF has a lot of work to do to convince shareholders and investors it will be able to overcome these large obstacles.Water-soluble cannabinoid products comingThe Green Organic Dutchman recently stated in a press release with Caliper Foods, that the results from "a preliminary human pharmacokinetic study of Caliper CBD" were promising.The study showed that Caliper Foods’ water-soluble CBD powder helped recipients experience a faster onset of the desired effect.It was described this way:"For this study, half of the participants were administered 30mg of Caliper Foods’ water-soluble CBD powder in 8oz of water while the other half received 30mg of CBD dispersed in MCT oil. Blood samples were drawn at pre-determined times over six hours. Early data shows that the group that received Caliper CBD demonstrated faster onset within 15 minutes, with higher concentrations achieved at 15 minutes compared to the maximum concentration achieved at 45 min with the CBD in oil formulation, and a 4.5-fold higher observed total bioavailability. The CBD was largely eliminated from the body after about 6 hours for both Caliper CBD and CBD oil subjects, and a more rapid reduction was observed with the Caliper CBD subjects after 45 minutes."As it relates to TGODF, it is targeting the commercialization of the organic cannabinoid dissolvables in Canada in the latter part of 2019, once the legalization of derivatives is in place.It's market it under its line of premium cannabis products, including in infused drinks, chewables, shots and teas.If demand is high enough it could make a significant impact on the top and bottom lines of the company, although I think it'll take time to play out.ConclusionThere can be no doubt that Aurora selling its stake in TGODF and going with its in-house organic producer and supplier Whistler was a huge blow to The Green Organic Dutchman.At a time when it was getting positioned to boost production capacity and have a lot of organic cannabis supply on hand, it's going to have to find ways to replace the approximate 20 percent of product Aurora going to buy from them.It also loses access to Aurora's distribution channels, which would it was planning on using to leverage and accelerate its pace of growth.For that reason and the others mentioned above, TGODF remains a very speculative play at a time when it should have been ready to go on all cylinders.A positive in all of this is if investors are willing to take a risk and put a little money in TGODF, the reward could be substantial.The key to its near-term performance will be the actual demand for organic cannabis in Canada, not based upon what people assert, but based upon what they actually buy. That and finding ways to rapidly get licensed in other Canadian provinces is a key to its immediate success.If it struggles to get licensed, it's going to take a lot more time than it thought to gain market share, or to even brand its products in markets it isn't even allowed to sell in at this time.Although it may appear to be a potential value play, it's quite possible it's priced right where it should be. If it does surprise to the upside, its modest share price will without a doubt take off. More recent articles from Smarter Analyst: * Cresco Labs Shares Down as Regulatory Uncertainty Weighs * Evercore Remains Bullish on Alphabet Stock as Antitrust Threat May Prove Less Than Feared * Meet Aurora Cannabis' (ACB) New Bear * HEXO Stock Could More Than Double in the Next 12 Months, Says Analyst
The Green Organic Dutchman Holdings Ltd (TSX: TGOD) (US: TGODF ) and water-soluble cannabinoid producer Caliper Foods announced Monday the results of a preliminary human pharmacokinetic study of Caliper ...
Higher cannabinoid absorption was observed for Caliper CBD within 15 minutes compared to the maximum absorption of CBD in oil in 45 minutes. TORONTO and DENVER , Sept. 9, 2019 /CNW/ - The Green Organic Dutchman Holdings Ltd. (the "Company" or "TGOD") (TGOD.TO) (TGODF), a leading producer of premium certified organic cannabis, and Caliper Foods (formerly Stillwater Foods), a best-in-class provider of water-soluble cannabinoid products, are pleased to unveil the results of a preliminary human pharmacokinetic ("PK") study of Caliper CBD, Caliper Foods' proprietary tasteless and odourless water-soluble powder that can be added to almost any food or beverage.
Alone among the "Big 4" Canadian cannabis companies, Edmonton, Alberta-based Aurora Cannabis (ACB) lacks a deep-pocketed "brand name" partnership in the world of consumer goods, to provide the funds it might need to broaden its business as the legal marijuana industry gains credibility, and expands into the consumer market. As a result, Aurora -- arguably more than any other Canadian cannabis stock -- has a real need to raise cash, and as brokerage Jefferies reports, this is a big reason why this week, Aurora raised some cash by cashing out its final block of shares in peer company The Green Organic Dutchman (TGOD).As Jefferies analyst Owen Bennett explained in a note yesterday, Aurora began investing in TGOD back in January 2018 with a 33.3 million-share purchase made at the bargain price of $1.65 a share. It doubled down on that bet when TGOD IPO'ed in May 2018, buying a further 6.3 million shares at $3.65 per share, raising its stake in TGOD to about 18%. But it soon became apparent that these were opportunistic -- not strategic -- investments on Aurora's part.In fact, by October of last year, Aurora had already begun unwinding its position in TGOD, selling off shares from October 2018 through January 2019 at prices ranging from $5 to $6 a share -- and even allowing warrants it had acquired to expire unexercised. This selling spree culminated Tuesday in Aurora's announcement that it would liquidate its remaining 10% stake in TGOD in a "block trade" at $3 per share -- about 15% below TGOD's market price at the time of the announcement.Why sell out, and more precisely, while sell out at a share price below what it had paid for much of its TGOD stake as recently as May of last year?For one thing, Bennett notes that at the same time as it was selling off its TGOD stake, Aurora was also casting acquisitive eyes at TGOD rival Whistler, which like TGOD, specializes in the production of "organic" cannabis, finally confirming its intention to buy Whistler outright in January 2019 in a $175 million deal. Unless Aurora intended to corner the market on organic weed, therefore (and perhaps invite antimonopoly scrutiny from Canadian regulators), it only made sense to sell TGOD in order to buy Whistler.But a second reason for liquidating its stake in TGOD, as Bennett also points out, was to raise cash. "The $86.5m" received for its TGOD shares "is a welcome cash boost for Aurora given a lack of financial backing vs larger peers," commented the analyst. And raising this cash helps to address "one of the main bear points we see around Aurora." It also, not incidentally, helps to avoid (or at least delay) the necessity of Aurora making further dilutive share issuances to raise the cash it needs to expand.What does it mean for TGOD?Of course, TGOD is itself a publicly-traded company, and investors in it may wonder what Aurora's selling-out means for them? In Bennett's opinion, it doesn't necessarily mean anything bad. For one thing, the reasons for Aurora selling out of TGOD are logical on their face, and don't necessarily imply that Aurora saw anything wrong with TGOD's business from which it wished to extricate itself. For another, with Aurora's ties to the company now severed, the way could be clear for another, more strategic buyer to make a bid for TGOD, and thus "get exposure to an attractive organic segment, given other players here are scarce."With Aurora out, there's now an opportunity for someone else to get in -- and should an acquirer emerge, this should only mean good things for TGOD's stock price.All in all, Bennett rates both ACB and TGOD a 'buy', with respective price targets of C$14.00 and C$6.50. (To watch Bennett's track record, click here)See Comparison results for ACB and TGOD:
TORONTO, Sept. 4, 2019 /PRNewswire/ - The Green Organic Dutchman Holdings Ltd. (the "Company" or "TGOD") (TSX:TGOD) (TGODF) comments on the recent transaction between Aurora Cannabis ("Aurora") (TSX:ACB) and a syndicate of Canadian banks. The block trade was executed on September 3 after market close. A total of 28.8 million shares were exchanged at a negotiated price of $3.00 per unit. The Edmonton-based company still retains a large number of TGOD warrants equivalent to approximately 5% of the Company's fully diluted shares.
TORONTO, Sept. 3, 2019 /PRNewswire/ - The Green Organic Dutchman Holdings Ltd. (the "Company" or "TGOD") (TGOD.TO) (TGODF), a leading producer of premium certified organic cannabis, is pleased to announce that it has obtained approval from Health Canada, under the Cannabis Regulations, to expand operations into its new hybrid greenhouse located in Hamilton, Ontario. The 123,000 square foot state-of-the-art facility will serve to increase TGOD's premium organic cannabis production as it expands its sales in Canada.
It’s no question that the marijuana industry is a budding space. The industry saw $10.9 billion in sales last year, not including sales that occurred illegally. Not to mention analysts predict this figure could jump by anywhere between $50 billion to $200 billion over the next ten years. However, somewhere along the way things went awry for cannabis stocks. A few have actually seen growth slow with some being bogged down by supply-side issues and tax concerns in the U.S. That’s not to say that these stocks won’t see upside again, but investors will have to be patient and pay close attention to determine whether or not they can recover. Analysts from Wall Street’s top firms highlight 3 beaten-down cannabis stocks to watch. Let's take a closer look: Canopy Growth Corporation (CGC)Many investors are wondering what happened to Canopy Growth. The prominent medical cannabis company has taken a beating in its last two quarters, with growth becoming stagnant. In its most recent quarter, CGC reported disappointing Q1 results that didn’t just miss but rather failed to come close to consensus estimates. While the company posted quarterly net revenue of CA$90.5 million, up by more than 3x from the year-ago quarter, investors were not impressed as this result was well below the Street’s CA$109 million estimate. More bad news came when CGC reported its net loss widened to CA$1.3 million from CA$91,000 in the prior-year quarter. Management attributes the loss to a drastic drop in cannabis oil and softgel sales, plunging to CA$0.2 million from CA$36.5 million in Q4. While some have placed the blame on channel stuffing or filling distribution channels with more product than is needed, others have pointed to new competitors that have zeroed in on CGC’s market share.CIBC analyst John Zamparo believes that the latter is the case with Canopy. “We believe the decline amounts to an unsustainable market share from the onset of adult-use legalization, with competitors now having improved their offering,” he explained. (To watch Zamparo's track record, click here) The analyst does note that its backing from Constellation Brands (STZ) as well as its 15 upcoming clinical trials and 270 patents lends itself to strong long-term growth prospects. “We believe investors will need to show patience to allow Canopy to build its international presence as clinical trials and patents take time to play out and eventually give Canopy Growth an advantage versus peers,” Zamparo added. As a result, Zamparo reiterated his Outperform rating on CGC but did drop the price target from $80 to $50. All in all, the rest of the Street is cautiously optimistic about CGC. With 9 Buy ratings vs 6 Holds received over the last three months, the consensus among analysts is that this cannabis stock is a ‘Moderate Buy’. Its $44 average price target suggests 57% upside potential. (See CGC’s price targets and analyst ratings on TipRanks) Tilray Inc. (TLRY)The second cannabis stock on our list, like CGC, didn’t exhibit the level of growth investors wanted to see. While Tilray’s second quarter revenue gained year-over-year, its losses more than doubled from the year-ago quarter. The company has failed to generate a profit in the year since its IPO, with management warning investors that this won’t change anytime soon. Investors are especially troubled by TLRY’s international sales. It trails behind its competitors in this segment of the business and has shown only small sequential improvement. That being said, TLRY has made efforts to expand its reach in the Portugal market with the GMP certification of its facility in the country. TLRY is also expanding its access to the domestic market by opening more retail locations in key Canadian provinces, including Ontario. Additionally, the cannabis company stands to benefit from the launch of the Canadian cannabis derivatives market in October. Jefferies analyst Ryan Tomkins argues that while TLRY hasn’t quite achieved a turnaround yet, the company is taking steps in the right direction. “Continued recreational revenue increases and expected international medical sales pickup obvious positives, but still reasons for caution in our view,” the analyst explained. The analyst adds on a positive note that management stated oversupply was not pressing as they once thought, and quality supply was scarce, which led to investments in expanding their own facilities. It was also able to launch a new broad spectrum CBD product under the Manitoba Harvest brand in the U.S. As all of these factors have not quelled his concerns, Tomkins reiterated his Hold rating and $57 price target on TLRY stock.All in all, the rest of the Street mirrors the analyst’s cautious sentiment, with TipRanks analytics showcasing TLRY as a Hold. (See TLRY’s price targets and analyst ratings on TipRanks) The Green Organic Dutchman Holdings (TGOD)Lackluster second quarter results have put a dark cloud over this cannabis stock. On August 13, TGOD reported that its sales for the quarter totaled CA$2.8 million, falling well below the CA$4.6 million consensus estimate. It didn’t help that its cash dropped from CA$214 million at the beginning of 2019 to CA$69 million in Q2. That being said, one analyst believes that concerns regarding sales and cash flow have been blown out of proportion. Tomkins, who also covers TGOD, points out that its sales only include revenue generated from the HemPoland segment of its business. Once the company’s new Grower’s Circle launch extends beyond its pilot program, Tomkins thinks sales should get a boost. “Any disappointment is misplaced, in our view. We see sales strongly picking up from here and with costs under control, we think the company is well placed to hit its target of turning a profit by the end of Q1 2020,” the Jefferies analyst added. As a result, Tomkins reiterated his Buy rating and CA$6.50 price target.TGOD announced it had received a purchase order from Ontario as well as new supply and distribution agreements with the provincial boards Alberta Cannabis and BC Cannabis stores, which management hopes will bolster sales. While these positive developments have led some to believe that the tide is turning for the marijuana stock, not all analysts are convinced TGOD has pulled off a turnaround. (See TGOD’s price targets and analyst ratings on TipRanks)
The next five days will still be full of news surrounding the cannabis space. We have compiled a list of main things that cannabis investors should be keeping an eye on this week. Ontario Lottery And New ...
TORONTO, Aug. 16, 2019 /PRNewswire/ - The Green Organic Dutchman Holdings Ltd. (the "Company" or "TGOD") (TGOD.TO) (TGODF), a leading producer of premium certified organic cannabis, is pleased to announce that it has completed its inaugural shipment to the Ontario Cannabis Store, marking the Company's entrance into Canada's recreational market. Ontario consumers will soon be able to experience TGOD's acclaimed Unite Organic dried flower, the Company's high THC signature strain, which will be available on www.ocs.ca as well as at select retail locations across the province.
CEO Brian Athaide says the company has received "overwhelmingly positive" feedback for its premium certified organic cannabis products.
Canadian cannabis producer Green Organic Dutchman Holdings Ltd (OTC: TGODF) reported its financial results for the second quarter, which included a revenue growth of 20% sequentially. Benzinga's Cannabis Capital Conference heads to Detroit on Aug. 15 — click here to learn more! Earlier this month, Green Organic Dutchman said it had applied to have its stock listed on the NASDAQ market.
TORONTO , Aug. 13, 2019 /CNW/ - The Green Organic Dutchman Holdings Ltd. (the "Company" or "TGOD") (TGOD.TO) (TGODF) is pleased to report its financial and operational results for the three and six months ended June 30, 2019 . In Canada , the Company launched its pilot "Grower's Circle", which included sales to a small number of medical patients to test the market and the Company's distribution capabilities. The Company launched two new products in Q2 and expects to start a similar pilot in the Ontario recreational market during Q3-2019.